StockTipsArenaBeta

BUY Neuland Laboratories Limited — Goldman Sachs

BUYNeuland Laboratories Limited
Neuland Laboratories share price target & all analyst calls

byGoldman SachsHorizon: NA (inferred 1 year)6 Aug 2026via ET Now (Live)

Entry₹21,800Inferred
Target₹23,300
Total upside +6.88% (call closed)
Stop lossNot given
Exit₹23,3007 Aug 2026, 12:08 pm
Target hit+6.88%0.00%upside left
Follow Goldman Sachs for new calls(100% target hit, 31 closed calls)Get alertsWatch NEULANDLAB for new buy/sell callsGet alertsSee 1 active Long-term call on NEULANDLABSee 278 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 7 Aug 2026
7 supporting2 neutral0 opposing
Supports the BUY call (7)

Neuland Labs shares surge 10% after Q1 results better analyst expectations, strong commentary

NewsCnbc-Tv18·6 Aug · yesterday

(opens in new tab)

Neuland Laboratories shares jump over 6% after 975% YoY surge in Q1 profit

NewsEt-Markets·6 Aug · yesterday

(opens in new tab)

Neuland Laboratories shares jump over 10% to record high after Q1FY27 results

NewsHbl·6 Aug · yesterday

(opens in new tab)

Neuland Laboratories Stock Surges 7% After Q1 Profit Swells 10-Fold

NewsNdtv-Profit·6 Aug · yesterday

(opens in new tab)

Neuland Laboratories Q1 profit jumps over 10-fold to ₹148 crore as margins surge

NewsCnbc-Tv18·5 Aug · yesterday

(opens in new tab)
Neutral / worth noting (2)

Neuland Laboratories announced a strategic collaboration with Gland Pharma for sterile API manufacturing. This partnership involves Gland Pharma establishing a new sterile manufacturing suite at its V

BSE · Board Meeting·5 Aug · yesterday

(opens in new tab)

Neuland Laboratories Ltd made an announcement regarding credit rating under Regulation 30 of LODR.

BSE · Company Update·13 Jul · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Neuland Laboratories

All analyst calls on Neuland Laboratories

More from Goldman Sachs

Every call and its outcome